More on AZRX

- Summary
- Chart
- Profile
- Historical

Data

- Ratings (8.3 Score)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

AzurRx BioPharma (NQ:AZRX)
Delayed: 0.79 -0.02 (2.47%)
Prev. Close $0.81  
Open$0.80 
52 Wk High$5.60 
52 Wk Low$3.98 
Day High$0.81 
Day Low$0.76 
P/E N/A  
EPS$0.00 
Volume1,599,733 

Friends, Peers and Foes (?): PPD (more...)

Apr 15, 2021 07:35 AM AzurRx BioPharma (AZRX) CEO Issues Letter to Shareholders
Apr 15, 2021 07:30 AM AzurRx BioPharma CEO Issues Letter to Shareholders
Apr 13, 2021 08:30 AM AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis
Apr 9, 2021 06:04 AM Form EFFECT AzurRx BioPharma, Inc.
Apr 6, 2021 04:16 PM Form POS AM AzurRx BioPharma, Inc.
Apr 6, 2021 07:01 AM AzurRx BioPharma (AZRX) Initiates Phase 2 Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Apr 6, 2021 07:00 AM AzurRx BioPharma Initiates Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Apr 1, 2021 09:29 AM Pre-Open Movers 04/01: (FTFT) (FNKO) (UTHR) Higher; (AZRX) (EBON) (XL) Lower (more...)
Apr 1, 2021 08:01 AM Form 8-K AzurRx BioPharma, Inc. For: Mar 31
Apr 1, 2021 06:18 AM AzurRx Biopharma (AZRX) PT Lowered to $2.50 at H.C. Wainwright
View All Articles

Entities mentioned with AZRX

View All Entities